Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
29
XRAY Quote, Financials, Valuation and Earnings
Last price:
$18.70
Seasonality move
:
3.58%
Day range:
$18.46 - $18.84
52-week range:
$17.21 - $37.60
Dividend yield:
3.32%
P/E ratio:
--
P/S ratio:
0.99x
P/B ratio:
1.49x
Volume:
10.3M
Avg. volume:
3.4M
1-year change:
-45.06%
Market cap:
$3.7B
Revenue:
$4B
EPS (TTM):
-$2.07
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $4B | $3.3B | $4.2B | $3.9B | $4B | |
| Revenue Growth (YoY) | 0.9% | -16.98% | 26.72% | -7.3% | 1.1% | |
| Cost of Revenues | $1.9B | $1.7B | $1.9B | $1.8B | $1.9B | |
| Gross Profit | $2.2B | $1.7B | $2.3B | $2.1B | $2.1B | |
| Gross Profit Margin | 53.8% | 49.6% | 55.47% | 54.23% | 52.61% | |
| R&D Expenses | $143M | $123M | $171M | $174M | $184M | |
| Selling, General & Admin | $1.6B | $1.3B | $1.6B | $1.6B | $1.6B | |
| Other Inc / (Exp) | -$69M | -$235M | -$19M | -$1.3B | -$376M | |
| Operating Expenses | $1.7B | $1.4B | $1.7B | $1.8B | $1.8B | |
| Operating Income | $434M | $231M | $625M | $357M | $282M | |
| Net Interest Expenses | $27M | $46M | $61M | $65M | $81M | |
| EBT. Incl. Unusual Items | $338M | -$50M | $545M | -$1.1B | -$175M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $82M | $23M | $134M | -$105M | -$43M | |
| Net Income to Company | $256M | -$73M | $411M | -$950M | -$132M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $256M | -$73M | $411M | -$950M | -$132M | |
| Basic EPS (Cont. Ops) | $1.15 | -$0.33 | $1.88 | -$4.41 | -$0.62 | |
| Diluted EPS (Cont. Ops) | $1.14 | -$0.33 | $1.87 | -$4.41 | -$0.62 | |
| Weighted Average Basic Share | $223.1M | $219.2M | $218.4M | $215.5M | $212M | |
| Weighted Average Diluted Share | $224.4M | $219.2M | $220.2M | $215.5M | $212M | |
| EBITDA | $688M | $330M | $952M | -$662M | $249M | |
| EBIT | $365M | -$4M | $606M | -$990M | -$94M | |
| Revenue (Reported) | $4B | $3.3B | $4.2B | $3.9B | $4B | |
| Operating Income (Reported) | $434M | $231M | $625M | $357M | $282M | |
| Operating Income (Adjusted) | $365M | -$4M | $606M | -$990M | -$94M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $883M | $1B | $947M | $947M | $951M | |
| Revenue Growth (YoY) | -8.22% | 17.78% | -8.94% | -- | 0.42% | |
| Cost of Revenues | $451M | $471M | $439M | $452M | $456M | |
| Gross Profit | $432M | $569M | $508M | $495M | $495M | |
| Gross Profit Margin | 48.92% | 54.71% | 53.64% | 52.27% | 52.05% | |
| R&D Expenses | $29M | $39M | $41M | $46M | $40M | |
| Selling, General & Admin | $313M | $395M | $401M | $373M | $391M | |
| Other Inc / (Exp) | -$19M | -$8M | -$1.3B | -$307M | -$524M | |
| Operating Expenses | $342M | $434M | $442M | $419M | $431M | |
| Operating Income | $90M | $135M | $66M | $76M | $64M | |
| Net Interest Expenses | $14M | $14M | $14M | $19M | $18M | |
| EBT. Incl. Unusual Items | $57M | $113M | -$1.2B | -$250M | -$478M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $9M | $29M | -$164M | $16M | $17M | |
| Net Income to Company | $58M | $84M | -$1.1B | -$266M | -$495M | |
| Minority Interest in Earnings | -$1M | -- | -- | -- | $1M | |
| Net Income to Common Excl Extra Items | $47M | $84M | -$1.1B | -$266M | -$494M | |
| Basic EPS (Cont. Ops) | $0.22 | $0.39 | -$5.01 | -$1.25 | -$2.46 | |
| Diluted EPS (Cont. Ops) | $0.22 | $0.38 | -$5.01 | -$1.25 | -$2.46 | |
| Weighted Average Basic Share | $218.5M | $218.6M | $214.9M | $211.8M | $201M | |
| Weighted Average Diluted Share | $219.2M | $220.5M | $214.9M | $211.8M | $201M | |
| EBITDA | $159M | $212M | -$1.1B | -$143M | -$371M | |
| EBIT | $71M | $127M | -$1.2B | -$231M | -$460M | |
| Revenue (Reported) | $883M | $1B | $947M | $947M | $951M | |
| Operating Income (Reported) | $90M | $135M | $66M | $76M | $64M | |
| Operating Income (Adjusted) | $71M | $127M | -$1.2B | -$231M | -$460M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $3.4B | $4.2B | $4B | $3.9B | $3.9B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1.7B | $1.9B | $1.8B | $1.9B | $1.9B | |
| Gross Profit | $1.7B | $2.3B | $2.2B | $2.1B | $2B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | $160M | $180M | $184M | $166M | |
| Selling, General & Admin | $1.3B | $1.5B | $1.6B | $1.6B | $1.6B | |
| Other Inc / (Exp) | -$228.5M | -$27M | -$1.3B | -$418M | -$531M | |
| Operating Expenses | $1.5B | $1.7B | $1.7B | $1.8B | $1.8B | |
| Operating Income | $203.6M | $603M | $470M | $279M | $248M | |
| Net Interest Expenses | $38M | $58M | $59M | $85M | $73M | |
| EBT. Incl. Unusual Items | -$62.9M | $518M | -$907M | -$224M | -$356M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $29.7M | $121M | -$91M | -$5M | $54M | |
| Net Income to Company | -$82.6M | $397M | -$816M | -$219M | -$410M | |
| Minority Interest in Earnings | -- | -- | -- | $5M | -$3M | |
| Net Income to Common Excl Extra Items | -$92.6M | $397M | -$816M | -$214M | -$413M | |
| Basic EPS (Cont. Ops) | -$0.39 | $1.79 | -$3.88 | -$1.00 | -$2.07 | |
| Diluted EPS (Cont. Ops) | -$0.39 | $1.77 | -$3.88 | -$1.01 | -$2.07 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | $298.6M | $924M | -$514M | $198M | $63M | |
| EBIT | -$26.9M | $576M | -$848M | -$139M | -$283M | |
| Revenue (Reported) | $3.4B | $4.2B | $4B | $3.9B | $3.9B | |
| Operating Income (Reported) | $203.6M | $603M | $470M | $279M | $248M | |
| Operating Income (Adjusted) | -$26.9M | $576M | -$848M | -$139M | -$283M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $2.2B | $3.1B | $2.9B | $3B | $2.9B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1.2B | $1.4B | $1.3B | $1.4B | $1.4B | |
| Gross Profit | $1.1B | $1.7B | $1.6B | $1.6B | $1.5B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $81M | $122M | $131M | $141M | $123M | |
| Selling, General & Admin | $933M | $1.2B | $1.2B | $1.2B | $1.2B | |
| Other Inc / (Exp) | -$223M | -$15M | -$1.3B | -$385M | -$540M | |
| Operating Expenses | $1B | $1.3B | $1.3B | $1.4B | $1.3B | |
| Operating Income | $62M | $447M | $292M | $214M | $180M | |
| Net Interest Expenses | $32M | $43M | $41M | $61M | $53M | |
| EBT. Incl. Unusual Items | -$193M | $389M | -$1.1B | -$232M | -$413M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$5M | $97M | -$128M | -$28M | $69M | |
| Net Income to Company | -$178M | $292M | -$935M | -$204M | -$482M | |
| Minority Interest in Earnings | -- | -- | -- | $5M | $2M | |
| Net Income to Common Excl Extra Items | -$188M | $292M | -$935M | -$199M | -$480M | |
| Basic EPS (Cont. Ops) | -$0.85 | $1.34 | -$4.35 | -$0.93 | -$2.39 | |
| Diluted EPS (Cont. Ops) | -$0.85 | $1.32 | -$4.35 | -$0.94 | -$2.39 | |
| Weighted Average Basic Share | $658.1M | $655.8M | $646.8M | $638.2M | $614M | |
| Weighted Average Diluted Share | $658.8M | $661.1M | $648M | $639.4M | $615.1M | |
| EBITDA | $86M | $693M | -$773M | $87M | -$99M | |
| EBIT | -$161M | $432M | -$1B | -$171M | -$360M | |
| Revenue (Reported) | $2.2B | $3.1B | $2.9B | $3B | $2.9B | |
| Operating Income (Reported) | $62M | $447M | $292M | $214M | $180M | |
| Operating Income (Adjusted) | -$161M | $432M | -$1B | -$171M | -$360M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $405M | $438M | $339M | $365M | $334M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $782M | $667M | $750M | $632M | $695M | |
| Inventory | $562M | $476M | $515M | $627M | $624M | |
| Prepaid Expenses | $121M | $111M | $111M | $128M | $146M | |
| Other Current Assets | $84M | $67M | $84M | $88M | $113M | |
| Total Current Assets | $2B | $1.8B | $1.9B | $1.9B | $2B | |
| Property Plant And Equipment | $961M | $967M | $971M | $961M | $978M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $3.4B | $4B | $4B | $2.7B | $2.4B | |
| Other Intangibles | $2.2B | $2.5B | $2.3B | $1.9B | $1.7B | |
| Other Long-Term Assets | $69M | $95M | $121M | $198M | $276M | |
| Total Assets | $8.6B | $9.4B | $9.2B | $7.6B | $7.4B | |
| Accounts Payable | $308M | $302M | $262M | $279M | $305M | |
| Accrued Expenses | $417M | $432M | $424M | $401M | $427M | |
| Current Portion Of Long-Term Debt | $2M | $299M | $12M | $23M | $97M | |
| Current Portion Of Capital Lease Obligations | $44M | $48M | $50M | $54M | $56M | |
| Other Current Liabilities | $3M | $32M | $3M | $19M | $18M | |
| Total Current Liabilities | $995M | $1.4B | $1.3B | $1.2B | $1.4B | |
| Long-Term Debt | $1.4B | $2B | $1.9B | $1.8B | $1.8B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $3.5B | $4.4B | $4.2B | $3.8B | $4.1B | |
| Common Stock | $3M | $3M | $3M | $3M | $3M | |
| Other Common Equity Adj | -$600M | -$464M | -$592M | -$628M | -$636M | |
| Common Equity | $5.1B | $4.9B | $5B | $3.8B | $3.3B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $2M | $3M | $1M | $1M | $1M | |
| Total Equity | $5.1B | $4.9B | $5B | $3.8B | $3.3B | |
| Total Liabilities and Equity | $8.6B | $9.4B | $9.2B | $7.6B | $7.4B | |
| Cash and Short Terms | $405M | $438M | $339M | $365M | $334M | |
| Total Debt | $1.4B | $2.3B | $2.1B | $1.9B | $2.1B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $1.3B | $281M | $418M | $309M | $296M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $628.1M | $748M | $645M | $649M | $671M | |
| Inventory | $489.1M | $532M | $592M | $651M | $619M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $190.4M | $243M | $284M | $304M | $335M | |
| Total Current Assets | $2.6B | $1.8B | $1.9B | $1.9B | $1.9B | |
| Property Plant And Equipment | $916.5M | $954M | $915M | $935M | $967M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $3.3B | $4B | $2.6B | $2.4B | $1.9B | |
| Other Intangibles | $2.1B | $2.4B | $1.9B | $1.7B | $1.5B | |
| Other Long-Term Assets | $59M | $128M | $209M | $268M | $263M | |
| Total Assets | $8.9B | $9.3B | $7.5B | $7.2B | $6.6B | |
| Accounts Payable | $242.8M | $276M | $271M | $262M | $297M | |
| Accrued Expenses | $564.1M | $641M | $711M | $732M | $798M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $1.2B | $1.1B | $1.3B | $1.2B | $1.5B | |
| Long-Term Debt | $1.9B | $1.9B | $1.7B | $1.8B | $1.8B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $4.1B | $4.2B | $3.9B | $3.8B | $4.1B | |
| Common Stock | $2.6M | $3M | $3M | $3M | $3M | |
| Other Common Equity Adj | -$577.6M | -$567M | -$844M | -$657M | -$638M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $1.8M | $3M | $1M | -$4M | -$1M | |
| Total Equity | $4.8B | $5.1B | $3.6B | $3.4B | $2.5B | |
| Total Liabilities and Equity | $8.9B | $9.3B | $7.5B | $7.2B | $6.6B | |
| Cash and Short Terms | $1.3B | $281M | $418M | $309M | $296M | |
| Total Debt | $2.2B | $2.1B | $2B | $2B | $2.2B | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $256M | -$73M | $411M | -$950M | -$132M | |
| Depreciation & Amoritzation | $323M | $334M | $346M | $328M | $343M | |
| Stock-Based Compensation | $66M | $47M | $48M | $59M | $46M | |
| Change in Accounts Receivable | -$90M | $131M | -$117M | $85M | -$58M | |
| Change in Inventories | $11M | $123M | -$64M | -$141M | $6M | |
| Cash From Operations | $639M | $649M | $657M | $517M | $377M | |
| Capital Expenditures | $123M | $87M | $142M | $149M | $149M | |
| Cash Acquisitions | $8M | -$1.1B | -$220M | -- | $13M | |
| Cash From Investing | -$69M | -$1.1B | -$358M | -$138M | -$89M | |
| Dividends Paid (Ex Special Dividend) | -$81M | -- | -$92M | -$104M | -$116M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $120M | $1.5B | $16M | $6M | -- | |
| Long-Term Debt Repaid | -$251M | -$701M | -$297M | -$2M | -$7M | |
| Repurchase of Common Stock | -$260M | -$228M | -$200M | -$150M | -$300M | |
| Other Financing Activities | -$40M | -$56M | -$36M | -$21M | -$10M | |
| Cash From Financing | -$472M | $476M | -$379M | -$329M | -$307M | |
| Beginning Cash (CF) | $310M | $405M | $438M | $339M | $365M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $98M | $19M | -$80M | $50M | -$19M | |
| Ending Cash (CF) | $405M | $438M | $339M | $365M | $334M | |
| Levered Free Cash Flow | $516M | $562M | $515M | $368M | $228M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $58M | $84M | -$1.1B | -$266M | -$495M | |
| Depreciation & Amoritzation | $88M | $85M | $82M | $88M | $89M | |
| Stock-Based Compensation | $17M | $22M | $14M | $2M | $12M | |
| Change in Accounts Receivable | -$119M | -$74M | -$10M | $7M | -$67M | |
| Change in Inventories | $74M | -$8M | -$45M | -$13M | $9M | |
| Cash From Operations | $221M | $172M | $109M | $134M | $141M | |
| Capital Expenditures | $21M | $35M | $32M | $37M | $43M | |
| Cash Acquisitions | -$2M | -$7M | -- | -- | -- | |
| Cash From Investing | -$25M | -$40M | -$26M | -$2M | -$47M | |
| Dividends Paid (Ex Special Dividend) | -$22M | -$24M | -$27M | -$29M | -$33M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $7M | $143M | $28M | -$73M | $56M | |
| Long-Term Debt Repaid | -- | -$297M | -- | -$5M | -$2M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -$100M | |
| Other Financing Activities | -$22M | -$3M | -$7M | -$2M | -- | |
| Cash From Financing | -$37M | -$179M | -$6M | -$109M | -$79M | |
| Beginning Cash (CF) | $1.1B | $332M | $362M | $295M | $279M | |
| Foreign Exchange Rate Adjustment | $4M | -$4M | -$21M | -$9M | $2M | |
| Additions / Reductions | $159M | -$47M | $77M | $23M | $15M | |
| Ending Cash (CF) | $1.3B | $281M | $418M | $309M | $296M | |
| Levered Free Cash Flow | $200M | $137M | $77M | $97M | $98M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$82.6M | $397M | -$816M | -$219M | -$410M | |
| Depreciation & Amoritzation | $325.5M | $348M | $334M | $337M | $346M | |
| Stock-Based Compensation | $52.2M | $65M | $41M | $45M | $48M | |
| Change in Accounts Receivable | $80.7M | -$108M | $15M | $11M | -$8M | |
| Change in Inventories | $132.4M | -$38M | -$116M | -$46M | $53M | |
| Cash From Operations | $690.5M | $699M | $597M | $359M | $534M | |
| Capital Expenditures | $96.1M | $128M | $158M | $141M | $169M | |
| Cash Acquisitions | -$2.3M | -$1.3B | $1M | -- | -- | |
| Cash From Investing | -$34.3M | -$1.4B | -$148M | -$98M | -$160M | |
| Dividends Paid (Ex Special Dividend) | -$88.3M | -$2M | -$102M | -$112M | -$125M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $1.4B | $163M | -$75M | $5M | $29M | |
| Long-Term Debt Repaid | -$633.4M | -$297M | -$2M | -$6M | -$9M | |
| Repurchase of Common Stock | -$240M | -$178M | -$260M | -$150M | -$400M | |
| Other Financing Activities | -$64.6M | -$11M | -$40M | -$13M | -$13M | |
| Cash From Financing | $389.3M | -$272M | -$290M | -$340M | -$392M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $1B | -$993M | $159M | -$79M | -$18M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $594.4M | $571M | $439M | $218M | $365M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$178M | $292M | -$935M | -$204M | -$482M | |
| Depreciation & Amoritzation | $247M | $261M | $249M | $258M | $261M | |
| Stock-Based Compensation | $36M | $54M | $47M | $33M | $35M | |
| Change in Accounts Receivable | $150M | -$89M | $43M | -$31M | $19M | |
| Change in Inventories | $73M | -$88M | -$140M | -$45M | $2M | |
| Cash From Operations | $385M | $435M | $375M | $217M | $374M | |
| Capital Expenditures | $60M | $101M | $117M | $109M | $129M | |
| Cash Acquisitions | -$2M | -$221M | -- | -- | -- | |
| Cash From Investing | -$5M | -$319M | -$109M | -$69M | -$140M | |
| Dividends Paid (Ex Special Dividend) | -$66M | -$68M | -$78M | -$86M | -$95M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $1.4B | $162M | $71M | $70M | $99M | |
| Long-Term Debt Repaid | -$701M | -$297M | -$2M | -$6M | -$8M | |
| Repurchase of Common Stock | -$140M | -$90M | -$150M | -$150M | -$250M | |
| Other Financing Activities | -$56M | -$11M | -$15M | -$7M | -$10M | |
| Cash From Financing | $491M | -$257M | -$168M | -$179M | -$264M | |
| Beginning Cash (CF) | $1.8B | $1.1B | $1.1B | $978M | $904M | |
| Foreign Exchange Rate Adjustment | -$4M | -$16M | -$19M | -$25M | -$8M | |
| Additions / Reductions | $871M | -$141M | $98M | -$31M | -$30M | |
| Ending Cash (CF) | $2.6B | $931M | $1.2B | $922M | $866M | |
| Levered Free Cash Flow | $325M | $334M | $258M | $108M | $245M | |
Get XRAY Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
XRAY
Sector
P/E ratio
--
25.86x
PEG ratio
-0.09x
0.00x
P/B ratio
1.49x
1.85x
Price / LTM sales
0.99x
1.86x
Growth Metrics
XRAY
Sector
Revenue growth
0.42%
7.28%
Earnings growth
--
1.82%
Revenue (5-year growth)
-0.11%
8.73%
Earnings forecast
$0.48
-$0.20
Profitability
XRAY
Sector
Profitability FY 2023
$2.1B
$57.1M
Return on invested capital
-7.95%
-14.06%
Return on assets
-5.86%
-11.77%
Return on equity
-13.34%
-14.78%
Earnings Date
Last Earnings Date
Nov
7
Next Earnings Date
Feb
28
Estimated Next Earnings Date
Feb
6
Balance Sheet
XRAY
Sector
Total cash
$296M
$47M
Short term investments
--
$45.2M
Total assets
$7.4B
$142.6M
Long term debt
$2.2B
$6.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
